Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)

CUSIP: 19249H103

Q2 2018 13F Holders as of 30 Jun 2018

Holder snapshot 7 signals
Share change
+6,677,228
Put/Call ratio
68%
SEC-reported price per share
$14.00
Number of holders
112
Value change
+$96,221,276
Number of buys
74
Open additional details 1 more signal available
Number of sells
38
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
153,624,096

Security key

19249H103

Report period

Q2 2018

Institutions

112

Top holders

10

Ownership snapshot

Top reported holders of CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
31 Mar 2018
13F Lead comparable stake: 5.1% Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 5.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership Top 5
WELLINGTON MANAGEMENT GROUP LLP 5.1%
FMR LLC 4.9%
Temasek Holdings (Private) Ltd 4.3%
BlackRock Finance, Inc. 2.2%
Kohlberg Kravis Roberts & Co. L.P. 2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
5.1%
$86,038,000
7,786,287 shares
31 Mar 2018
FMR LLC
13F
Company
13F
4.9%
$82,733,000
7,487,137 shares
31 Mar 2018
Temasek Holdings (Private) Ltd
13F
Company
13F
4.3%
$72,445,000
6,556,116 shares
31 Mar 2018
BlackRock Finance, Inc.
13F
Company
13F
2.2%
$36,837,000
3,333,724 shares
31 Mar 2018
Kohlberg Kravis Roberts & Co. L.P.
13F
Company
13F
2%
$33,758,000
3,055,055 shares
31 Mar 2018
Sofinnova Investments, Inc.
13F
Company
13F
1.9%
$31,970,000
2,893,221 shares
31 Mar 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
112
Shares
61,953,349
Rows available
112
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders
102
Q2 2018 holders
112
Holder diff
10
Investor Q1 2018 Shares Q2 2018 Shares Share Diff Share Chg % Q1 2018 value Q2 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .